ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Celera Corp. (MM)

Celera Corp. (MM) (CRA)

8.04
0.00
(0.00%)
Closed August 25 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
8.04
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
8.04
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CRA Latest News

Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement of the Celera Corp. Securities Litigation

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Celera Corp. Securities Litigation: UNITED STATES DISTRICT COURTNORTHERN DISTRICT OF...

Quest Diagnostics Successfully Completes Acquisition of Celera

Quest Diagnostics Successfully Completes Acquisition of Celera PR Newswire MADISON, N.J., May 17, 2011 MADISON, N.J., May 17, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the...

Quest Diagnostics To Complete Celera Deal Through Short-Form Merger

Quest Diagnostics Inc. (DGX) plans to complete its deal for genetics-diagnostics test developer Celera Corp. (CRA) through a short-form merger, as the company announced that it held 61% of...

Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option

Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger PR Newswire MADISON, N.J., May 11, 2011...

Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera

Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera Offer Concludes at 5 p.m. Tomorrow, Tuesday, May 10th PR Newswire MADISON, N.J., May 9, 2011...

Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera

Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera PR Newswire MADISON, N.J., May 4, 2011 MADISON, N.J., May 4, 2011...

Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today

Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today Over 52% of Fully-Diluted Shares Tendered to Date, Including Guaranteed Shares PR Newswire MADISON, N.J., May...

Earnings Scorecard: Quest Diagnostics - Analyst Blog

The announcement of Quest Diagnostics’ (DGX) first quarter of fiscal 2011 results as on April 20, 2011, has triggered analysts to revise estimates downwards. Previous quarter...

LabCorp Beats, Raises EPS Guidance - Analyst Blog

Leading lab-testing company Laboratory Corporation of America Holdings (LH) reported adjusted EPS of $1.52 (excluding amortization, restructuring and other special charges) for the first quarter...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRTGPortage Biotech Inc
$ 5.90
(118.49%)
49.67M
MNTSMomentus Inc
$ 1.04
(80.65%)
231.74M
GHSIGuardion Health Sciences Inc
$ 17.91
(58.50%)
561.42k
RETOReTo Eco Solutions Inc
$ 1.591
(52.98%)
3.45M
HUBCWHub Cyber Security Ltd
$ 0.0149
(40.57%)
40.79k
UBXGU BX Technology Ltd
$ 2.38
(-92.54%)
35.79M
FAMIFarmmi Inc
$ 0.2336
(-58.76%)
14.1M
GDCGD Culture Group Ltd
$ 5.43
(-29.94%)
28.75M
NUWENewellis Inc
$ 1.26
(-26.74%)
754.69k
TGLTreasure Global Inc
$ 0.85
(-25.44%)
1.4M
NVDANVIDIA Corporation
$ 129.37
(4.55%)
323.15M
MNTSMomentus Inc
$ 1.04
(80.65%)
231.74M
SQQQProShares UltraPro Short QQQ
$ 7.98
(-3.16%)
186.3M
MULNMullen Automotive Inc
$ 0.3321
(-7.62%)
140.97M
APDNApplied DNA Sciences Inc
$ 2.4901
(36.07%)
127.34M

CRA Discussion

View Posts
UserAlias1 UserAlias1 10 years ago
.
👍️0
datakid datakid 13 years ago
CRA: BVF bought more CRA stock recently www.prontosec.com/secdata/dailyReport.htm, why pay price higher than sale price of $8 paid by DGX?
👍️0
conix conix 14 years ago
CRA Short Interest

Short Interest (Shares Short)
3,757,700
👍️0
conix conix 14 years ago
CRA hits the list of option traders/speculators expecting a rebound

Celera Corporation (CRA)Market cap of $474.72M.

Call open interest at 1,392 contracts vs. put open interest at 171 contracts (Put/Call ratio at 0.12).

Short float at 5.23% of public float.
👍️0
surf1944 surf1944 14 years ago
7:01AM Celera Genomics publishes data extending the association between the KIF6 gene variant and differential reduction of coronary events from statin therapy to the elderly with prior vascular disease (CRA) 6.98 : Co announces the publication of data reporting that elderly carriers of the KIF6 gene variant with prior vascular disease received significant benefit from pravastatin therapy. Previous research has shown that a variant of the KIF6 gene, a member of the molecular motor protein kinesin family, is associated with up to a 55% increased risk of primary and recurrent coronary heart disease events in the placebo arms of the clinical trials, and that this increased risk is virtually eliminated with statin therapy. The effect of pravastatin versus placebo on coronary events according to KIF6 carrier status was investigated among 5,752 patients of the PROspective Study of Pravastatin in the Elderly at Risk study.
👍️0